BY ALBERT RONNING-ANDERSSON
-
Novo Nordisk follows competitor: New AI director to boost competitiveness
United States drugmaker Eli Lilly employed its very first AI supervisor back in October in 2015, and currently Novo Nordisk is additionally in the middle of a comparable employment…
-
GSK to harness supercomputers in fight against antimicrobial resistance
A budget plan of GBP 45m has actually been alloted for supercomputers and expert system.
-
Ascendis Pharma continues growth spurt – generating revenue of USD 248.35m in Q3
The pharmaceutical team Ascendis Pharma enhanced its earnings by 35% in the 3rd quarter.
-
Fired Hoba CEO lands new top job in Italy
In September, he was rejected from Hoba, which is had by Novo Holdings, Eifo, and Eir Ventures, however Torsten M. Madsen has actually currently been designated chief executive off…
-
Danish state fund expects solid returns on major investment in French venture capital firm
Danish state fund EIFO is investing EUR 20m in life science venture capital firm Sofinnova Partners, with the expectation that the firm will focus on Danish companies.
-
Abbott makes major investment in cancer screening – pays USD 23bn for US diagnostics company
The purchase places amongst the leading 5 biggest within medtech and diagnostics in current times, claims Claus Henrik Johansen, chief executive officer of the financial investment…
-
WSA posts first profit in five years, paving way for possible stock market listing
Financial debt and tailoring remain to decrease, albeit from a really high base. “Points are relocating the ideal instructions,” claims WSA CFO Marianne Wiinholt.
-
Authorities approve Demant’s acquisition of KIND
Currently just the “normal closing problems” stay prior to the celebrations can finish the deal, which totals up to EUR 700 million, equal to DKK 5.2 billion.
-
Nordic manager for Stallergenes Greer resigns after two years
With brand-new head offices in Copenhagen, Brice Chouquet, nation supervisor Nordics for Stallergenes Greer, was entrusted with damaging ALK’s syndicate on the Danish market.…
-
GSK to harness supercomputers in fight against antimicrobial resistance
A budget of GBP 45m has been allocated for supercomputers and artificial intelligence.
